Nature Made® Ranked as #1 Pharmacist Recommended Vitamin and Supplement Brand in Pharmacy Times Annual Survey
KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
New 'supercharged' drug can protect nerve cells that lead to Alzheimer's
Bristol-Myers Squibb Company ( BMY ) announced that ONO-4538-12, a Phase 3 clinical trial evaluating the efficacy and safety of Opdivo (nivolumab) in patients with unresectable advanced or recurrent gastric cancer refractory to, or intolerant of, standard therapy, met its primary endpoint of overall survival. Ono Pharma of Japan, Bristol-Myers Squibb's development partner for Opdivo, conducted the ONO-4538-12 trial. The companies will work with investigators on the future presentation of the study results.
Vitalah® is committed to providing the highest quality dietary supplements, and part of that commitment is ensuring that each formulation includes the safest, most efficacious ingredients on the market. That's why Vitalah recently made three upgrades to its Adult Oxylent® formula: switching the source of folate from folic acid to 5-MTHF (5-methyltetrahydrofolate); changing the source of iodine from potassium iodide to kelp; and adding in sources of vitamins A and E.
Vitamin A Slows Fetal Blood Cell Growth
Food Supplements Crucial to Reduce Child Malnutrition
Vitamin A may protect kids against malaria
India Leads Malnutrition Chart In South Asia: Tribals, Scheduled Castes Worse Off